Stryker PEEK Customized Implant: A Prospective Post Market Follow Up to Evaluate Safety, Performance and Effectiveness
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Ilka Meinert, Ph.D
- Phone Number: +49 170 384 5636
- Email: Ilka.meinert@stryker.com
Study Contact Backup
- Name: Stephanie John, Ph.D
- Phone Number: +41 79 651 3268
- Email: sjo@qmed-consulting.com
Study Locations
-
-
-
Graz, Austria, 8036
- Universitätsklinik für Neurochirurgie Auenbruggerplatz 29
-
-
-
-
Occitanie
-
Toulouse, Occitanie, France, TSA 40031 - 31059
- Pierre-Paul Riquet Hospital, Place du Docteur Baylac, Cedex 9
-
-
Paris France
-
Paris, Paris France, France, 75010
- APHP - Hôpital Lariboisière Neurochirurgie 2 rue Ambroise Paré
-
-
Pays de la Loire Region
-
Nantes, Pays de la Loire Region, France, 44093
- CHU Nantes - Hopital Guillaume et Rene Laënnec, Cedex 1
-
-
-
-
Hamm
-
Hamm, Hamm, Germany, 59073
- St. Barbara-Klinik Hamm GmbH Hamm Heessen und St. Josef-Krankenhaus Hamm-Bockum-Hövel Am Heessener Wald 1 | 1263
-
-
North Rhine-Westphalia
-
Dortmund, North Rhine-Westphalia, Germany, 44145
- Klinik für Neurochirurgie Klinikum Dortmund Münsterstr. 240
-
-
-
-
Madrid
-
Madrid, Madrid, Spain, 28046
- Servicio de Neurocirugía Hospital Universitario La Paz.
-
-
-
-
London
-
London, London, United Kingdom, SW7 2AZ
- Neurosurgery, Emergency and Major Trauma (NET) Research | Division of Medicine | Imperial College Healthcare NHS Trust
-
-
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- University of Louisville 501 E. Broadway, Suite 210
-
-
New Jersey
-
New Brunswick, New Jersey, United States, 07101-1709
- Department of Neurological Surgery
-
-
New York
-
New York, New York, United States, 10032
- Department of Neurological Surgery, 710 West 168th Street, 4th Floor, New York Presbyterian Hospital
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19140
- Lewis Katz School of Medicine at Temple University, 3401 North Broad Street
-
-
South Carolina
-
Charleston, South Carolina, United States, 29425
- Medical University of South Carolina, Oral & Maxillofacial Surgery, 173 Ashley Avenue, Charleston, USA
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria
- Subject is eligible for a PEEK customized implant as per routine clinical practice.
- Subject is 12 years of age or older (Europe only).
- Subject is 3.5 years of age or older (USA only).
- Adult subjects able to give consent.
- Subjects under the age of 18 will have a legal representative or parents (France - both parents must sign) to provide informed consent.
- Subjects who are unable to give consent themselves but have a legally authorized representative that may consent on their behalf.
Exclusion Criteria
- Subject has an active systemic or local infection.
- Subject has known allergy to plastic or polymers and/or known sensitivity to foreign bodies.
- Comprised bone due to poor blood supply, disease, infection or prior implantation, which would not allow adequate support or fixation of the implant.
- Mental or neuromuscular disorder which could create an unacceptable risk of implant instability or implant fixation failure, or complications in postoperative care.
- Knowingly pregnant or nursing women.
- Concomitant participation in other clinical trials related to cranioplasty.
- Subject who has an expected survival rate of less than 2 years, in the opinion of the investigator who takes consent.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Cohort 1
Participants will receive a Stryker PEEK Customized Implant
|
The PEEK Customized Implants will be used in this patient cohort for augmentation and/or restoration of bony and/or soft tissue deformities in the cranial and craniofacial skeleton (orbital rim, zygoma, and adjacent bone); including but not limited to, the correction and prevention of persistent temporal hollowing (PTH).
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Infection Rate
Time Frame: Up to 24 months post-operative
|
Assessment of rate of infection associated with Stryker's PEEK Customized Implants.
|
Up to 24 months post-operative
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of device related serious adverse events (SAEs)
Time Frame: Up to 24 months post-operative
|
Incidence of device related SAEs up to 24 months post implantation
|
Up to 24 months post-operative
|
|
Ability to place the Customized Implant during surgery leading to good aesthetic outcome
Time Frame: Up to 24 months post-operative
|
Assessment of success of placement by the surgeon as determined by the ability to close the defect effectively, even with modification of implant
|
Up to 24 months post-operative
|
|
Rate of implant failure
Time Frame: Up to 24 months post-operative
|
Rate of implant failure leading to explantation
|
Up to 24 months post-operative
|
|
Quality of life questionnaire
Time Frame: Up to 24 months post-operative
|
Outcome of Short Form health survey-12 (SF-12) quality of life questionnaire
|
Up to 24 months post-operative
|
|
Length of hospitalisation
Time Frame: 1 month
|
Time duration after surgery until hospital discharge
|
1 month
|
|
Persistent temporal hollowing
Time Frame: Up to 24 months post-operative
|
Presence of persistent temporal hollowing after the procedure
|
Up to 24 months post-operative
|
|
Neurological Assessment
Time Frame: Up to 24 months post-operative
|
Glasgow Coma Scale
|
Up to 24 months post-operative
|
|
Scale of brain injuries
Time Frame: Up to 24 months post-operative
|
Glasgow Outcome Scale Extended
|
Up to 24 months post-operative
|
|
Aesthetic assessment
Time Frame: Up to 24 months post-operative
|
Aesthetic assessment score
|
Up to 24 months post-operative
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CMF_2021_01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.